Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > DMT stroke trial commences with first patient dosed

View:

Post by XeniaTechie on Jan 24, 2023 3:17pm

DMT stroke trial commences with first patient dosed

Algernon announces they’ve dosed the first subject in the Phase 1 DMT clinical stroke study. This study is being conducted at the Centre for Human Drug Research in Leiden, Netherlands. The first part of this study will use a single-escalating dose design aimed at identifying a safe and tolerable dose that will not produce psychedelic effects. AGN’s DMT trial also positions them as one of the cheapest psychedelic stocks on the market. https://www.youtube.com/watch?v=BfjAjt1jxuU

135

Comment

Comment by waves1 on Jan 24, 2023 5:00pm

There is significant potential here as AGN is taking a new approach to stroke treatment that greatly differs from the previous stroke drug treatments that failed. By focusing on promoting neuroplasticity with DMT, AGN could make a breakthrough here.

Comment

Algernon Pharmaceuticals Inc.